SpyGlass Pharma, Inc. (SGP): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$32.70M

Year ended 2025-12-31

-$46.56M

Trailing 12 months to 2026-06-30

2024-12-31 Operating Cash Flow (USD) 2025-12-31

Period ended	Operating Cash Flow	Change YoY	Source filing
2025-12-31	-$32.70M	n/m	2026-03-26, From 2025-01-01
2024-12-31	-$22.03M	n/a	2026-03-26, From 2024-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Cash Flow	Change YoY
SpyGlass Pharma, Inc. (SGP)	2025-12-31	-$32.70M	n/m
Sight Sciences, Inc. (SGHT)	2025-12-31	-$29.69M	n/m
Orchestra BioMed Holdings, Inc. (OBIO)	2025-12-31	-$48.96M	n/m
Fractyl Health, Inc. (GUTS)	2025-12-31	-$90.33M	n/m
DarioHealth Corp. (DRIO)	2025-12-31	-$25.94M	n/m
Utah Medical Products Inc (UTMD)	2025-12-31	$14.69M	-0.9%
Iradimed Corp (IRMD)	2025-12-31	$24.95M	-2.6%
Delcath Systems, Inc. (DCTH)	2025-12-31	$22.52M	n/m
Alpha Tau Medical Ltd. (DRTS)	2025-12-31	-$26.68M	n/m

Compare SGP, SGHT, OBIO, GUTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗